{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T23:56:37Z","timestamp":1777938997064,"version":"3.51.4"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T00:00:00Z","timestamp":1776643200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T00:00:00Z","timestamp":1776643200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100019014","name":"Chengdu Municipal Science and Technology Program","doi-asserted-by":"publisher","award":["2024-YF05-00858-SN"],"award-info":[{"award-number":["2024-YF05-00858-SN"]}],"id":[{"id":"10.13039\/501100019014","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018542","name":"Natural Science Foundation of Sichuan Province","doi-asserted-by":"publisher","award":["2022NSFSC1562"],"award-info":[{"award-number":["2022NSFSC1562"]}],"id":[{"id":"10.13039\/501100018542","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Oncol"],"DOI":"10.1007\/s12032-026-03293-8","type":"journal-article","created":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T08:28:55Z","timestamp":1776673735000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Diosmetin overcomes resistance to cisplatin in ovarian cancer by suppressing the MAPK signaling pathway"],"prefix":"10.1007","volume":"43","author":[{"given":"Juan","family":"Nie","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hequn","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Runyu","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruichen","family":"Gong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenli","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ping","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ling","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin","family":"Lyu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,4,20]]},"reference":[{"key":"3293_CR1","doi-asserted-by":"publisher","DOI":"10.1007\/s12032-025-02888-x","author":"E Erdo\u011fan","year":"2025","unstructured":"Erdo\u011fan E, \u00d6zdem B, \u00c7imentepe \u00d6\u00d6, Tekedereli \u0130. Anatolian propolis extracts enhance cisplatin efficacy in ovarian cancer through AKT\/mTOR pathway modulation and demonstrate antibacterial and antibiofilm activities. Med Oncol. 2025. https:\/\/doi.org\/10.1007\/s12032-025-02888-x.","journal-title":"Med Oncol"},{"key":"3293_CR2","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1136\/jmedgenet-2021-108402","volume":"60","author":"ME Barnard","year":"2022","unstructured":"Barnard ME, Meeks H, Jarboe EA, Albro J, Camp NJ, Doherty JA. Familial risk of epithelial ovarian cancer after accounting for gynaecological surgery: A population-based study. J Med Genet. 2022;60:119\u201327.","journal-title":"J Med Genet"},{"key":"3293_CR3","doi-asserted-by":"publisher","DOI":"10.1007\/s12032-022-01763-3","author":"C Ha","year":"2022","unstructured":"Ha C, Hu L, Ren Y, Yang J, Xin L. SND1 confers chemoresistance to cisplatin-induced apoptosis by targeting GAS6-AKT in SKOV3 ovarian cancer cells. Med Oncol. 2022. https:\/\/doi.org\/10.1007\/s12032-022-01763-3.","journal-title":"Med Oncol"},{"key":"3293_CR4","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-024-01967-3","author":"L Wang","year":"2024","unstructured":"Wang L, Wang X, Zhu X, Zhong L, Jiang Q, Wang Y, et al. Drug resistance in ovarian cancer: from mechanism to clinical trial. Mol Cancer. 2024. https:\/\/doi.org\/10.1186\/s12943-024-01967-3.","journal-title":"Mol Cancer"},{"key":"3293_CR5","doi-asserted-by":"publisher","first-page":"4611","DOI":"10.3390\/ijms26104611","volume":"26","author":"B Smolarz","year":"2025","unstructured":"Smolarz B, Biernacka K, \u0141ukasiewicz H, Samulak D, Piekarska E, Romanowicz H, et al. Ovarian cancer\u2014epidemiology, classification, pathogenesis, treatment, and estrogen receptors \u2019 molecular backgrounds. Int J Mol Sci. 2025;26:4611.","journal-title":"Int J Mol Sci"},{"key":"3293_CR6","doi-asserted-by":"publisher","DOI":"10.1007\/s12032-025-02628-1","author":"EK Siahestalkhi","year":"2025","unstructured":"Siahestalkhi EK, Demiray A, Yaren A, Demiray AG, Tan S, Ak\u00e7a H. Characterization of lncRNAs contributing to drug resistance in epithelial ovarian cancer. Med Oncol. 2025. https:\/\/doi.org\/10.1007\/s12032-025-02628-1.","journal-title":"Med Oncol"},{"key":"3293_CR7","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.ccr.2015.11.004","volume":"310","author":"M Fanelli","year":"2016","unstructured":"Fanelli M, Formica M, Fusi V, Giorgi L, Micheloni M, Paoli P. New trends in platinum and palladium complexes as antineoplastic agents. Coord Chem Rev. 2016;310:41\u201379.","journal-title":"Coord Chem Rev"},{"key":"3293_CR8","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.canlet.2016.01.009","volume":"373","author":"Z Ai","year":"2016","unstructured":"Ai Z, Lu Y, Qiu S, Fan Z. Overcoming cisplatin resistance of ovarian cancer cells by targeting HIF-1-regulated cancer metabolism. Cancer Lett. 2016;373:36\u201344.","journal-title":"Cancer Lett"},{"key":"3293_CR9","doi-asserted-by":"publisher","DOI":"10.1097\/cad.0000000000001682","author":"X Li","year":"2025","unstructured":"Li X, Guo Y, Qia Z, Zheng Y. WDR62 mediates MAPK\/ERK pathway to stimulate DNA damage repair and attenuate cisplatin sensitivity in lung adenocarcinoma. Anticancer Drugs. 2025. https:\/\/doi.org\/10.1097\/cad.0000000000001682.","journal-title":"Anticancer Drugs"},{"key":"3293_CR10","doi-asserted-by":"publisher","first-page":"2207","DOI":"10.1038\/sj.jid.5700870","volume":"127","author":"A Mirmohammadsadegh","year":"2007","unstructured":"Mirmohammadsadegh A, Mota R, Gustrau A, Hassan M, Nambiar S, Marini A, et al. ERK1\/2 is highly phosphorylated in melanoma metastases and protects melanoma cells from cisplatin-mediated apoptosis. J Invest Dermatol. 2007;127:2207\u201315.","journal-title":"J Invest Dermatol"},{"key":"3293_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2019.109091","volume":"117","author":"J Choi","year":"2019","unstructured":"Choi J, Lee DH, Park SY, Seol JW. Diosmetin inhibits tumor development and block tumor angiogenesis in skin cancer. Biomed Pharmacother. 2019;117:109091.","journal-title":"Biomed Pharmacother"},{"key":"3293_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1055\/s-0041-1742095","volume":"13","author":"J Wang","year":"2022","unstructured":"Wang J, Ma S, Li L, Chen Y, Yang Q, Wang F, et al. Investigation into the in vivo mechanism of diosmetin in patients with breast cancer and COVID-19 using bioinformatics. Front Pharmacol. 2022;13:1\u201312.","journal-title":"Front Pharmacol"},{"key":"3293_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/molecules24142522","volume":"24","author":"S Koosha","year":"2019","unstructured":"Koosha S, Mohamed Z, Sinniah A, Alshawsh MA. Evaluation of anti-tumorigenic effects of diosmetin against human colon cancer xenografts in athymic nude mice. Molecules. 2019;24:1\u201311.","journal-title":"Molecules"},{"key":"3293_CR14","doi-asserted-by":"publisher","first-page":"531","DOI":"10.3390\/biomedicines10030531","volume":"10","author":"S Kamran","year":"2022","unstructured":"Kamran S, Sinniah A, Chik Z, Alshawsh MA. Diosmetin exerts synergistic effects in combination with 5-fluorouracil in colorectal cancer cells. Biomedicines. 2022;10:531.","journal-title":"Biomedicines"},{"key":"3293_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-019-41685-1","volume":"9","author":"S Koosha","year":"2019","unstructured":"Koosha S, Mohamed Z, Sinniah A, Alshawsh MA. Investigation into the molecular mechanisms underlying the anti-proliferative and anti-tumorigenesis activities of Diosmetin against HCT-116 human colorectal cancer. Sci Rep. 2019;9:1\u201317.","journal-title":"Sci Rep"},{"key":"3293_CR16","first-page":"1","volume":"38","author":"F Zhao","year":"2021","unstructured":"Zhao F, Hong X, Li D, Wei Z, Ci X, Zhang S. Diosmetin induces apoptosis in ovarian cancer cells by activating reactive oxygen species and inhibiting the Nrf2 pathway. Med Oncol. 2021;38:1\u20139.","journal-title":"Med Oncol"},{"key":"3293_CR17","doi-asserted-by":"publisher","DOI":"10.2174\/0118715206360266250115065234","author":"J Li","year":"2025","unstructured":"Li J, Xu M, Wu N, Wu F, Chen J, Xu X, et al. Effects of citrus-derived diosmetin on melanoma: induction of apoptosis and autophagy mediated by PI3K\/Akt\/mTOR pathway inhibition. Anticancer Agents Med Chem. 2025. https:\/\/doi.org\/10.2174\/0118715206360266250115065234.","journal-title":"Anticancer Agents Med Chem"},{"key":"3293_CR18","doi-asserted-by":"publisher","DOI":"10.3390\/ijms151019265","author":"W Li","year":"2014","unstructured":"Li W, Wan L, Zhai LY, Wang J. Effects of SC-560 in combination with cisplatin or taxol on angiogenesis in human ovarian cancer xenografts. Int J Mol Sci. 2014. https:\/\/doi.org\/10.3390\/ijms151019265.","journal-title":"Int J Mol Sci"},{"key":"3293_CR19","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/580626","author":"ST Chan","year":"2014","unstructured":"Chan ST, Lin YC, Chuang CH, Shiau RJ, Liao JW, Yeh SL. Oral and intraperitoneal administration of quercetin decreased lymphocyte DNA damage and plasma lipid peroxidation induced by TSA in vivo. BioMed Res Int. 2014. https:\/\/doi.org\/10.1155\/2014\/580626.","journal-title":"BioMed Res Int"},{"key":"3293_CR20","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1016\/j.jconrel.2015.09.007","volume":"220","author":"SS Desale","year":"2015","unstructured":"Desale SS, Soni KS, Romanova S, Cohen SM, Bronich TK. Targeted delivery of platinum-taxane combination therapy in ovarian cancer. J Control Release. 2015;220:651\u20139.","journal-title":"J Control Release"},{"key":"3293_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/cancers11030416","volume":"11","author":"A Madariaga","year":"2019","unstructured":"Madariaga A, Lheureux S, Oza AM. Tailoring ovarian cancer treatment: Implications of BRCA1\/2 mutations. Cancers (Basel). 2019;11:1\u201332.","journal-title":"Cancers (Basel)"},{"key":"3293_CR22","first-page":"1","volume":"2","author":"UA Matulonis","year":"2016","unstructured":"Matulonis UA, Sood AK, Fallowfield L, Howitt BE, Sehouli J, Karlan BY. Ovarian cancer. Nat Rev Dis Prim. 2016;2:1\u201322.","journal-title":"Nat Rev Dis Prim"},{"key":"3293_CR23","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.1038\/onc.2014.136","volume":"34","author":"QH Miow","year":"2014","unstructured":"Miow QH, Tan TZ, Ye J, Lau JA, Yokomizo T, Thiery JP, et al. Epithelial-mesenchymal status renders differential responses to cisplatin in ovarian cancer. Oncogene. 2014;34:1899\u2013907.","journal-title":"Oncogene"},{"key":"3293_CR24","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/j.biopha.2018.03.092","volume":"102","author":"X Ju","year":"2018","unstructured":"Ju X, Yu H, Liang D, Jiang T, Liu Y, Chen L, et al. LDR reverses DDP resistance in ovarian cancer cells by affecting ERCC-1, Bcl-2, Survivin and Caspase-3 expressions. Biomed Pharmacother. 2018;102:549\u201354.","journal-title":"Biomed Pharmacother"},{"key":"3293_CR25","doi-asserted-by":"publisher","first-page":"5200","DOI":"10.7150\/thno.27806","volume":"8","author":"F Zhou","year":"2018","unstructured":"Zhou F, Yang X, Zhao H, Liu Y, Feng Y, An R, et al. Down-regulation of OGT promotes cisplatin resistance by inducing autophagy in ovarian cancer. Theranostics. 2018;8:5200\u201312.","journal-title":"Theranostics"},{"key":"3293_CR26","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1007\/s12094-019-02167-y","volume":"22","author":"J Feliu","year":"2020","unstructured":"Feliu J, Heredia-Soto V, Giron\u00e9s R, Jim\u00e9nez-Munarriz B, Salda\u00f1a J, Guill\u00e9n-Ponce C, et al. Management of the toxicity of chemotherapy and targeted therapies in elderly cancer patients. Clin Transl Oncol. 2020;22:457\u201367.","journal-title":"Clin Transl Oncol"},{"key":"3293_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/cddis.2015.143","volume":"6","author":"N Mohell","year":"2015","unstructured":"Mohell N, Alfredsson J, Fransson A, Uustalu M, Bystr\u00f6m S, Gullbo J, et al. APR-246 overcomes resistance to cisplatin and doxorubicin in ovarian cancer cells. Cell Death Dis. 2015;6:1\u201311.","journal-title":"Cell Death Dis"},{"key":"3293_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40659-021-00363-1","volume":"54","author":"R Ning","year":"2021","unstructured":"Ning R, Chen G, Fang R, Zhang Y, Zhao W, Qian F. Diosmetin inhibits cell proliferation and promotes apoptosis through STAT3\/c-Myc signaling pathway in human osteosarcoma cells. Biol Res. 2021;54:1\u201315.","journal-title":"Biol Res"},{"key":"3293_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2020.173366","volume":"883","author":"Y Liu","year":"2020","unstructured":"Liu Y, Shao Z, Liao Y, Xia X, Huang C, He J, et al. Targeting SKP2\/Bcr-Abl pathway with Diosmetin suppresses chronic myeloid leukemia proliferation. Eur J Pharmacol. 2020;883:173366.","journal-title":"Eur J Pharmacol"},{"key":"3293_CR30","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1016\/j.apsb.2018.01.008","volume":"8","author":"F Liu","year":"2018","unstructured":"Liu F, Yang X, Geng M, Huang M. Targeting ERK, an Achilles\u2019 Heel of the MAPK pathway, in cancer therapy. Acta Pharm Sin B. 2018;8:552\u201362.","journal-title":"Acta Pharm Sin B"},{"key":"3293_CR31","doi-asserted-by":"publisher","first-page":"3446","DOI":"10.1002\/cncr.28864","volume":"120","author":"M Burotto","year":"2014","unstructured":"Burotto M, Chiou VL, Lee JM, Kohn EC. The MAPK pathway across different malignancies: A new perspective. Cancer. 2014;120:3446\u201356.","journal-title":"Cancer"},{"key":"3293_CR32","doi-asserted-by":"publisher","DOI":"10.4161\/cbt.6.2.3577","author":"NM Weir","year":"2007","unstructured":"Weir NM, Selvendiran K, Kutala VK, Tong L, Vishwanath S, Rajaram M, et al. Curcumin induces G2\/M arrest and apoptosis in cisplatin-resistant human ovarian cancer cells by modulating Akt and p38 MAPK. Cancer Biol Ther. 2007. https:\/\/doi.org\/10.4161\/cbt.6.2.3577.","journal-title":"Cancer Biol Ther"},{"key":"3293_CR33","doi-asserted-by":"publisher","DOI":"10.3390\/ph16050755","author":"P Hankittichai","year":"2023","unstructured":"Hankittichai P, Thaklaewphan P, Wikan N, Ruttanapattanakul J, Potikanond S, Smith DR, et al. Resveratrol enhances cytotoxic effects of Cisplatin by inducing cell cycle arrest and apoptosis in ovarian adenocarcinoma SKOV-3 cells through activating the p38 MAPK and suppressing AKT. Pharmaceuticals. 2023. https:\/\/doi.org\/10.3390\/ph16050755.","journal-title":"Pharmaceuticals"},{"key":"3293_CR34","doi-asserted-by":"publisher","DOI":"10.1007\/s11033-023-09026-8","author":"MR Karimzadeh","year":"2024","unstructured":"Karimzadeh MR, Masoudi Chelegahi A, Shahbazi S, Reiisi S. Co-treatment of silymarin and cisplatin inhibited cell proliferation, induced apoptosis in ovarian cancer. Mol Biol Rep. 2024. https:\/\/doi.org\/10.1007\/s11033-023-09026-8.","journal-title":"Mol Biol Rep"},{"key":"3293_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12032-024-02593-1","volume":"42","author":"F Irannejad","year":"2025","unstructured":"Irannejad F, Shahbazi S, Reiisi S, Heidari R. Study of the effect of zinc oxide, selenium, and silver nanoparticles on the expression level of oxidative stress-associated genes in ovarian cancer. Med Oncol. 2025;42:1\u201316.","journal-title":"Med Oncol"},{"key":"3293_CR36","doi-asserted-by":"publisher","DOI":"10.1186\/s43042-025-00647-1","author":"A Shirani","year":"2025","unstructured":"Shirani A, Mirabbasi R, Shabani L, Reiisi S. Pyrogallol acts as a novel anticancer factor to enhance the sensitivity to cisplatin in ovarian cancer cells through inducing miR-15a upregulation. Egypt J Med Hum Genet. 2025. https:\/\/doi.org\/10.1186\/s43042-025-00647-1.","journal-title":"Egypt J Med Hum Genet"},{"key":"3293_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.tiv.2023.105687","author":"F Omidi","year":"2023","unstructured":"Omidi F, Shahbazi S, Reiisi S, Azhdari S, Karimzadeh MR. Glycyrrhizic acid enhances the anticancer activity of cisplatin in the human ovarian cancer cell line. Toxicol In Vitro. 2023. https:\/\/doi.org\/10.1016\/j.tiv.2023.105687.","journal-title":"Toxicol In Vitro"}],"container-title":["Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-026-03293-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12032-026-03293-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-026-03293-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T04:59:38Z","timestamp":1777697978000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12032-026-03293-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,20]]},"references-count":37,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,5]]}},"alternative-id":["3293"],"URL":"https:\/\/doi.org\/10.1007\/s12032-026-03293-8","relation":{},"ISSN":["1559-131X"],"issn-type":[{"value":"1559-131X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,20]]},"assertion":[{"value":"28 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}},{"value":"The mouse experiment was approved by the Animal Welfare Ethics Committee at Chengdu Medical College (IACUC-24\u2013090).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"181"}}